HQL
abrdn Life Sciences Investors
NYSE · Financial Services · Asset Management · US
$19.41
−0.82%Margins
Gross margin
100.0%
EBITDA margin
99.1%
EBIT margin
99.1%
Net margin
99.1%
FCF margin
-2.7%
15.3%
Return on equity
15.2%
Return on assets
15.3%
Return on invested capital
0.16x
Asset turnover
-$2.3M
Cash from operations
$0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026